Xybion Corporation announced that its Pristima Preclinical Software suite has been selected as the primary preclinical platform for early-stage drug discovery pathology data management by a Top-5 global biotech firm.

CEDAR KNOLLS, NJ: Xybion Corporation announced that its Pristima Preclinical Software suite has been selected as the primary preclinical platform for early-stage drug discovery pathology data management by a Top-5 global biotech firm. The new Xybion client becomes the third major biotech laboratory in the Cambridge Massachusetts Biotechnology Re..

View more at http://www.1888pressrelease.com/preclinical-software/xybion/xybion-announces-a-major-biotechnology-company-licenses-pris-pr-392194.html